Quarterly report pursuant to Section 13 or 15(d)

Note 6 - Related Party Transactions (Details Textual)

v3.24.1.u1
Note 6 - Related Party Transactions (Details Textual)
$ in Thousands
3 Months Ended
Mar. 31, 2024
USD ($)
Tactic Pharma, LLC [Member]  
Related Party Transaction, Amounts of Transaction $ 0
Tactic Pharma, LLC [Member] | Monopar Therapeutics [Member]  
Equity Method Investment, Ownership Percentage 24.50%